Although Steven struggled with his vision for a decade, it wasn’t until he suggested to his wife that they get a bigger television that he realized his declining eyesight was becoming problematic. After deciding to take matters into his own hands, Steven visited multiple eye doctors and was shocked to learn he was living with keratoconus, a progressive eye condition.

Grappling with Deteriorating Vision  

Steven is a 38-year-old father to two young girls and a loving husband to his wife, Elizabeth. He enjoys reading, spending time with family, and preaching to his congregation as a pastor. However, his deteriorating vision began to impact all of these experiences that Steven cherished. He struggled to view the bible at church and read to his children at night. It became more and more challenging to recognize people, as their faces appeared blurry to him. He was also irritated with the constant eye rubbing and pain he was experiencing. 

One day, after struggling to see the television and suggesting that his family purchase a bigger one, his wife asked him to read a license plate from a distance. They were both shocked to realize that Steven could barely read the big letters and numbers on his license plate. His vision was far worse than they had expected.

In an effort to get to the bottom of his declining eyesight, Steven visited a local eye doctor, where he was told he had astigmatism and was given a prescription for glasses. Unfortunately, Steven’s vision continued to worsen, and he started to have trouble seeing at night. Because of this, he found himself searching for answers online, wondering if he was going blind and if he would ever be able to see his kids again. Steven felt truly fearful and concerned about his future. Knowing something wasn’t right, Steven sought a second opinion and visited Dr. Tyler Amos for a vision exam. While at the appointment, Dr. Amos expressed concerns about his driving and wondered if he had keratoconus. He referred Steven to Dr. Benjamin Pendergrass. 

Finding Answers and Hope

During his visit with Dr. Pendergrass, the two discussed the possibility of keratoconus, and what Steven’s next steps would be. Dr. Pendergrass referred Steven to Dr. Jack Parker of Parker Cornea in Birmingham, Alabama, where he was officially diagnosed with progressive keratoconus. As a young father, pastor, and husband, Steven wondered what his life would be like after receiving this new diagnosis. 

Steven’s journey began when Dr. Parker recommended he receive iLink® FDA-approved cross-linking to slow or halt the progression of his keratoconus. After learning more about his condition and discussing the procedure with Dr. Parker, Steven began to feel more comfortable knowing he would be in good hands and that a treatment was available which can help preserve his vision. Not wanting to wait any longer, Steven had his left eye treated with iLink® on June 14, 2019, then his right eye in June of 2020. After his procedures, he was also fitted with scleral lenses and soon began to feel hopeful. He noticed he was starting to see more clearly with an appropriate corrective lens.

Brighter Days Ahead

Since undergoing iLink® FDA-approved cross-linking, Steven is thrilled to have his life back. He is enjoying going to the beach, watching the leaves change color, reading books to his children, speaking to his congregation, and seeing the small details that he was once missing. Steven and his wife Elizabeth are also keeping a watchful eye on their children, by making sure they are receiving eye exams, paying attention in school, and looking out for any potential signs of keratoconus. As Steven and his family look forward to the future, Steven is hopeful he can inspire and encourage others with keratoconus, helping them to understand that they are not alone on this journey and that there are safe and effective treatment options available. 


Find a Cornea Cross-Linking Specialist Near You:

Search our physician locator to find a corneal specialist who is familiar with treating progressive keratoconus.

The results described on this site are based on data collected regarding short- and intermediate-term efficacy of treatment. Individual results are not guaranteed and may vary.

MA-02398 Rev 1